Jack Johnson

2.2k total citations
30 papers, 1.5k citations indexed

About

Jack Johnson is a scholar working on Molecular Medicine, Epidemiology and Pharmacology. According to data from OpenAlex, Jack Johnson has authored 30 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Medicine, 13 papers in Epidemiology and 9 papers in Pharmacology. Recurrent topics in Jack Johnson's work include Antibiotic Resistance in Bacteria (15 papers), Pneumonia and Respiratory Infections (9 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). Jack Johnson is often cited by papers focused on Antibiotic Resistance in Bacteria (15 papers), Pneumonia and Respiratory Infections (9 papers) and Antibiotics Pharmacokinetics and Efficacy (9 papers). Jack Johnson collaborates with scholars based in United States, Canada and France. Jack Johnson's co-authors include Daryl J. Hoban, George G. Zhanel, Brian Johnson, Michael J. Dowzicky, Nancy M. Laing, Samuel K. Bouchillon, Melanie DeCorby, Ayman Noreddin, Tamiko Hisanaga and S. Bouchillon and has published in prestigious journals such as Analytical Chemistry, Antimicrobial Agents and Chemotherapy and Obstetrics and Gynecology.

In The Last Decade

Jack Johnson

29 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jack Johnson United States	16	676	656	332	273	265	30	1.5k
Antonia C. Kastoris Greece	9	701 1.0×	524 0.8×	310 0.9×	115 0.4×	79 0.3×	10	1.1k
Evan Tzanis United States	23	380 0.6×	392 0.6×	418 1.3×	350 1.3×	92 0.3×	68	1.6k
Sanjay Merchant United States	16	282 0.4×	184 0.3×	179 0.5×	141 0.5×	132 0.5×	53	945
Mark H. Gotfried United States	34	988 1.5×	1.3k 2.0×	1.2k 3.5×	441 1.6×	154 0.6×	87	3.4k
Jay Ward Kislak United States	18	250 0.4×	407 0.6×	241 0.7×	296 1.1×	194 0.7×	28	1.0k
Robert Tipping United States	15	397 0.6×	227 0.3×	330 1.0×	422 1.5×	55 0.2×	28	1.3k
Eun‐Jeong Joo South Korea	25	285 0.4×	674 1.0×	117 0.4×	746 2.7×	269 1.0×	91	1.8k
Philip J. Turner United Kingdom	21	797 1.2×	261 0.4×	480 1.4×	97 0.4×	187 0.7×	38	1.2k
Zubair Qureshi United States	15	1.1k 1.6×	388 0.6×	512 1.5×	117 0.4×	157 0.6×	21	1.4k
Amy Manley United States	15	341 0.5×	327 0.5×	459 1.4×	313 1.1×	84 0.3×	28	1.1k

Countries citing papers authored by Jack Johnson

Since Specialization

Citations

This map shows the geographic impact of Jack Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack Johnson more than expected).

Fields of papers citing papers by Jack Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack Johnson. The network helps show where Jack Johnson may publish in the future.

Co-authorship network of co-authors of Jack Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Jack Johnson. A scholar is included among the top collaborators of Jack Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack Johnson. Jack Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Johnson, Jack, et al.. (2024). Patient-reported experience with Fabry disease and its management in the real-world setting: results from a double-blind, cross-sectional survey of 280 respondents. Orphanet Journal of Rare Diseases. 19(1). 153–153. 1 indexed citations

Wanner, Christoph, Alberto Ortíz, William R. Wilcox, et al.. (2023). Global reach of over 20 years of experience in the patient-centered Fabry Registry: Advancement of Fabry disease expertise and dissemination of real-world evidence to the Fabry community. Molecular Genetics and Metabolism. 139(3). 107603–107603. 18 indexed citations

Morand, Olivier, et al.. (2019). Symptoms and Quality of Life in Patients with Fabry Disease: Results from an International Patient Survey. Advances in Therapy. 36(10). 2866–2880. 24 indexed citations

Nichol, Kimberly A., et al.. (2006). Molecular epidemiology of urinary tract isolates of vancomycin-resistant Enterococcus faecium from North America. International Journal of Antimicrobial Agents. 27(5). 392–396. 27 indexed citations

Zhanel, George G., Tamiko Hisanaga, Nancy M. Laing, et al.. (2006). Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). International Journal of Antimicrobial Agents. 27(6). 468–475. 226 indexed citations

Doyle, R.J., et al.. (2006). Multiplexed PCR genotyping of HPVs from plantaris verrucae. Journal of Clinical Virology. 35(4). 435–441. 9 indexed citations

Zhanel, George G., Tamiko Hisanaga, Nancy M. Laing, et al.. (2005). Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). International Journal of Antimicrobial Agents. 26(5). 380–388. 173 indexed citations

Bouchillon, S., et al.. (2005). Impact of carbon dioxide on the susceptibility of key respiratory tract pathogens to telithromycin and azithromycin. Journal of Antimicrobial Chemotherapy. 56(1). 224–227. 2 indexed citations

Bouchillon, S., Brian Johnson, D. Hoban, et al.. (2004). Determining incidence of extended spectrum β-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001–2002. International Journal of Antimicrobial Agents. 24(2). 119–124. 123 indexed citations

10.

Bouchillon, S., D. J. Hoban, Jack Johnson, et al.. (2004). In vitro activity of gemifloxacin and contemporary oral antimicrobial agents against 27,247 Gram-positive and Gram-negative aerobic isolates: a global surveillance study. International Journal of Antimicrobial Agents. 23(2). 181–196. 13 indexed citations

11.

Hoban, D. J., S. Bouchillon, Jack Johnson, et al.. (2003). Comparative In Vitro Surveillance of Amoxicillin-Clavulanic Acid and Four Oral Comparators Against 21,232 Clinical Isolates from Europe. European Journal of Clinical Microbiology & Infectious Diseases. 22(4). 261–267. 4 indexed citations

12.

Hoban, D. J., S. Bouchillon, Jack Johnson, et al.. (2003). Comparative in vitro potency of amoxycillin–clavulanic acid and four oral agents against recent North American clinical isolates from a global surveillance study. International Journal of Antimicrobial Agents. 21(5). 425–433. 14 indexed citations

13.

Hoban, D. J., S. Bouchillon, Jack Johnson, et al.. (2001). Comparative In Vitro Potency of Gemifloxacin and Fluoroquinolones Against Recent European Clinical Isolates from a Global Surveillance Study. European Journal of Clinical Microbiology & Infectious Diseases. 20(11). 814–819. 13 indexed citations

14.

Hoban, D. J., S. Bouchillon, Jack Johnson, et al.. (2001). Comparative in vitro activity of gemifloxacin, ciprofloxacin, levofloxacin and ofloxacin in a North American surveillance study. Diagnostic Microbiology and Infectious Disease. 40(1-2). 51–57. 24 indexed citations

15.

Hoban, D. J., S. Bouchillon, James A. Karlowsky, et al.. (2000). A Comparative In Vitro Surveillance Study of Gemifloxacin Activities against 2,632 Recent Streptococcus pneumoniae Isolates from across Europe, North America, and South America. Antimicrobial Agents and Chemotherapy. 44(11). 3008–3011. 25 indexed citations

16.

Johnson, Jack, et al.. (1999). The effect of carbon dioxide on susceptibility testing of azithromycin, clarithromycin and roxithromycin against clinical isolates of Streptococcus pneumoniae and Streptococcus pyogenes by broth microdilution and the Etest: Artemis Project—first-phase study. Clinical Microbiology and Infection. 5(6). 327–330. 9 indexed citations

17.

Bouchillon, S., et al.. (1998). Susceptibility of European respiratory tract isolates to trovafloxacin, ciprofloxacin, clarithromycin, azithromycin and ampicillin. European Journal of Clinical Microbiology & Infectious Diseases. 17(6). 413–419. 18 indexed citations

18.

Thorp, James A., et al.. (1995). Combined antenatal vitamin K and phenobarbital therapy for preventing intracranial hemorrhage in newborns less than 34 weeks' gestation. Obstetrics and Gynecology. 86(1). 1–8. 30 indexed citations

19.

Smith, Edward D. & Jack Johnson. (1963). Measurement and Use of Substrate and Partition Liquid Selectivities in Gas Chromatography.. Analytical Chemistry. 35(9). 1204–1207. 8 indexed citations

20.

Garrett, Edward R., et al.. (1962). Analysis and Comparison of Ultraviolet Spectrophotometric Curves of Steroids with Application of the Analog Computer.. Analytical Chemistry. 34(11). 1472–1476. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact